Posaconazole Injection — FDA Drug Shortage

To Be Discontinued — Merck Sharp & Dohme Corp.

The FDA lists a drug shortage record for Posaconazole Injection (injection) from Merck Sharp & Dohme Corp. with status To Be Discontinued. The shortage was first posted on Dec 2, 2025.

Shortage details

Status
To Be Discontinued
Company
Merck Sharp & Dohme Corp.
Package NDC
0085-4331-01
Dosage Form
Injection
Presentation
Noxafil, Injection, 18 mg/1 mL (NDC 0085-4331-01)
Initial Posting
Dec 2, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.